Efficacy and Safety of T-DXd in Patients With HER2-positive and HER2-low Metastatic Breast Cancer: a Real-world Study
Clinical trial NCT07108595 · COMPLETED
Trial details
- NCT number
- NCT07108595
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2024-08-31
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.